ストックスクリーナーアプリを入手
3.485
8.77%
-0.335
前日終値:
$3.82
開ける：
$3.88
24時間の取引高:
2.58M
Relative Volume:
0.81
時価総額：
$928.29M
収益：
-
当期純損益:
$-252.18M
株価収益率:
-3.2877
EPS:
-1.06
ネットキャッシュフロー:
$-185.29M
1週間 パフォーマンス:
-18.38%
1か月 パフォーマンス:
-1.83%
6か月 パフォーマンス:
+17.74%
1年 パフォーマンス:
+36.67%
1日の値動き範囲:
$3.45
$3.88
1週間の範囲:
$3.45
$4.26
52週間の値動き範囲:
$1.26
$6.55
Sana Biotechnology Inc Stock (SANA) Company Profile
名前
Sana Biotechnology Inc
セクター
電話
(206) 701-7914
住所
188 EAST BLAINE STREET, SUITE 350, SEATTLE
Compare SANA vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
3.485 | 1.02B | 0 | -252.18M | -185.29M | -1.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.36 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
765.45 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
724.67 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.19 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.66 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-24 | 開始されました | Wedbush | Outperform |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-03-18 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 開始されました | Jefferies | Buy |
| 2025-01-08 | アップグレード | TD Cowen | Hold → Buy |
| 2024-11-05 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 開始されました | Rodman & Renshaw | Buy |
| 2024-01-16 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-05 | 開始されました | Citigroup | Buy |
| 2023-08-14 | 開始されました | TD Cowen | Market Perform |
| 2023-05-02 | 開始されました | H.C. Wainwright | Neutral |
| 2021-03-01 | 開始されました | BofA Securities | Buy |
| 2021-03-01 | 開始されました | Goldman | Neutral |
| 2021-03-01 | 開始されました | JP Morgan | Neutral |
| 2021-03-01 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Sana Biotechnology Inc (SANA) 最新ニュース
What is HC Wainwright's Forecast for SANA FY2030 Earnings? - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Cut to Hold at Zacks Research - MarketBeat
Citizens reiterates Sana Biotechnology stock rating on pipeline progress - Investing.com Nigeria
AI Adoption Exposes Sana Biotechnology to Rising Data, Compliance, and Reputational Risks - TipRanks
Sana Biotechnology (NASDAQ:SANA) Price Target Lowered to $7.00 at HC Wainwright - MarketBeat
Sana Biotech's Q4 Net Loss Expands; Plans To Submit IND For SC451 In 2026; Stock Down - Nasdaq
Sana Biotechnology files for mixed shelf size not disclosedSEC filing - marketscreener.com
Sana Biotechnology Files For Mixed Shelf Size Not DisclosedSEC Filing - TradingView
Sana Biotechnology (NASDAQ: SANA) files ATM to raise up to $150M with TD Cowen - Stock Titan
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates - Bitget
Sana: Overview of Fourth Quarter Financial Results - Bitget
Sana Biotechnology Updates ATM Program to Support Development - TipRanks
Earnings Flash (SANA) Sana Biotechnology, Inc. Posts Q4 Adjusted Loss $0.16 per Share, vs. FactSet Est of $-0.14 - marketscreener.com
Going concern risk and focused pipeline at Sana Biotechnology (NASDAQ: SANA) - Stock Titan
Sana Biotechnology (NASDAQ: SANA) sets $150.0 million ATM program - Stock Titan
SANA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sana Biotechnology, Inc. (SANA): A Bull Case Theory - Yahoo Finance
Sana Biotechnology (SANA) Stock Analysis: Exploring a Potential 104% Upside with Innovative Cell Therapies - DirectorsTalk Interviews
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Sana Biotechnology (SANA) Appoints Industry Veteran Brian Piper as New CFO - Yahoo Finance
Assessing Sana Biotechnology (SANA) Valuation After The Appointment Of A New CFO - Yahoo Finance
Will Sana’s New Veteran Biopharma CFO Appointment Change Sana Biotechnology's (SANA) Investment Narrative - Sahm
Assessing Sana Biotechnology (SANA) Valuation After Recent Share Price Momentum - simplywall.st
Hear Sana Biotechnology’s March investor talks live and on replay - Stock Titan
Sana Biotechnology to Present at March 2026 Investor Conferences - Yahoo Finance
Is Sana Biotechnology Inc a stock for growth or value investorsTreasury Yields & Daily Oversold Bounce Ideas - baoquankhu1.vn
Genomics Stocks That Deserve a Place in Your Portfolio in 2026 - TradingView
Sana Biotechnology, Inc. (SANA) Stock Analysis: Unveiling a 110% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Sana Biotechnology (SANA) CFO awarded new RSUs and 900,000 options - Stock Titan
Sana Biotechnology Names Brian Piper as New CFO - The Globe and Mail
All You Need to Know About Sana (SANA) Rating Upgrade to Buy - MSN
Sana Biotechnology stock falls after naming new CFO By Investing.com - Investing.com South Africa
Sana Biotechnology, Inc. Appoints Brian Piper as Chief Financial Officer - marketscreener.com
Sana Biotechnology, Inc. Announces Executive Changes - marketscreener.com
Sana Biotechnology stock falls after naming new CFO - Investing.com
Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer - Bitget
Sana Biotechnology (SANA) Rated ‘Market Perform’ on Diabetes Program Prospects - MSN
What’s the outlook for Sana Biotechnology Inc.’s sectorGDP Growth & Proven Capital Preservation Tips - mfd.ru
Assessing Sana Biotechnology (SANA) Valuation As Analyst Downgrade And FDA Scrutiny Weigh On Sentiment - Sahm
Is Sana Biotechnology Inc. benefiting from interest rate changesTrade Analysis Summary & Daily Entry Point Trade Alerts - mfd.ru
Sana Biotechnology: A Small, Speculative Play (NASDAQ:SANA) - Seeking Alpha
Will Sana Biotechnology Inc. benefit from geopolitical trendsFed Meeting & Reliable Volume Spike Alerts - mfd.ru
Will Sana Biotechnology Inc. benefit from sector rotationJuly 2025 Trade Ideas & AI Driven Price Predictions - mfd.ru
Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions - Quantisnow
Day Trade: What is the Moat Score of Sana Biotechnology IncJuly 2025 Drop Watch & Fast Entry Momentum Alerts - baoquankhu1.vn
Sana Biotechnology (NASDAQ:SANA) Downgraded by Wall Street Zen to Sell - MarketBeat
Commit To Purchase Sana Biotechnology At $2.50, Earn 26% Using Options - Nasdaq
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Flagship Pioneering Appoints Paul Owen as CEO-Partner and CEO of YourBio Health - Quantisnow
Sana Biotechnology, Inc. (SANA) Stock Analysis: 89% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know - Yahoo Finance
Sana Biotechnology Inc (SANA) 財務データ
収益
当期純利益
現金流量
EPS
Sana Biotechnology Inc (SANA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Wyrick Susan D. | See Remarks |
Jan 02 '26 |
Option Exercise |
0.00 |
7,500 |
0 |
188,290 |
| Wyrick Susan D. | See Remarks |
Dec 13 '25 |
Option Exercise |
0.00 |
3,400 |
0 |
181,663 |
| Wyrick Susan D. | See Remarks |
Dec 03 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
180,828 |
| Wyrick Susan D. | See Remarks |
Jun 03 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
170,395 |
| Wyrick Susan D. | See Remarks |
Mar 07 '25 |
Option Exercise |
0.00 |
3,250 |
0 |
158,231 |
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
4.35%
大文字化:
|
ボリューム (24 時間):